Keyphrases
Vascular Surgery
72%
Coenzyme Q10
66%
Arteriovenous Fistula
66%
Smooth muscle Cell Proliferation
56%
Supplemental Oxygen
56%
Intimal Hyperplasia
53%
Open Vascular Surgery
37%
Myocardial Injury
33%
Oxygen Administration
33%
Randomized Double-blind Trial
33%
C-reactive Protein Level
33%
Readmission
33%
Stanford Type B Aortic Dissection
33%
Weekend Admission
33%
Telemedicine
33%
Endovascular Intervention
33%
Renal Artery
33%
Occlusive Disease
33%
Kidney Failure
33%
Hypoxia
33%
Renal Artery Stenosis
33%
Factor Level
33%
Vascular Endothelial Growth Factor
33%
Telemedicine Consultations
33%
Thoracic Endovascular Aortic Repair (TEVAR)
33%
Hypoxia-inducible factor-1α (HIF-1α)
33%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
33%
Small Hospitals
33%
Type A Aortic Dissection
33%
Small Media
33%
Hospital Size
33%
Stanford Type A Aortic Dissection
33%
High Mortality
33%
Hypoxia-inducible Factor
26%
Large Hospital
26%
NT-proBNP Levels
25%
Type B Aortic Dissection
23%
Placebo
23%
Length of Stay
21%
C-reactive Protein
20%
Hyperoxic
20%
Normoxic
20%
After Surgery
18%
Hazard Ratio
16%
Confidence Interval
16%
B-type Natriuretic Peptide
16%
Veterans Affairs Medical Center
16%
Vascular Surgeon
16%
Short-term Administration
15%
High Incidence
15%
Medicine and Dentistry
Vascular Surgery
100%
Arteriovenous Fistula
66%
Aortic Dissection
66%
Cell Proliferation
56%
Smooth Muscle Cell
56%
Brain Natriuretic Peptide
47%
Intimal Hyperplasia
45%
C Reactive Protein
36%
Heart Muscle Injury
33%
Telemedicine
33%
Oxygen Therapy
33%
Renal Artery
33%
Renal Artery Stenosis
33%
Arteriosclerosis Obliterans
33%
Renal Failure
33%
Endovascular Aneurysm Repair
33%
Hypoxia
33%
Vasculotropin
33%
Hypoxia Inducible Factor
33%
Placebo
23%
Hazard Ratio
14%
Stenosis
13%
Protein Kinase B
12%
Biological Marker
12%
National Inpatient Sample
9%
Health Care Cost
9%
Comorbidity
9%
Surgeon
8%
Veterans Affairs
8%
Cytokine
8%
Randomized Controlled Trial
7%
Diabetes Mellitus
7%
Ischemic Heart Disease
7%
Patient Population
6%
Essential Hypertension
6%
Coronary Angiography
6%
Patient with Hypertension
6%
Renin-Angiotensin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Natriuretic Peptide
47%
C Reactive Protein
36%
Heart Muscle Injury
33%
Hypoxia
33%
Hypoxia Inducible Factor
33%
Leporidae
33%
Arteriovenous Fistula
33%
Vasculotropin
33%
Aortic Dissection
33%
Placebo
23%
Hyperplasia
12%
Protein Kinase B
12%
Biological Marker
12%
Cytokine
8%
Ischemic Heart Disease
7%
Randomized Controlled Trial
7%
Diabetes Mellitus
7%
Troponin
7%
